These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23463093)

  • 1. Prospective study of adjuvant radiotherapy on preventing lymph node metastasis after Ivor-lewis esophagectomy in esophageal cancer.
    Chen H; Wang Z; Yang Z; Shang B; Liu X; Chen G
    Ann Surg Oncol; 2013 Aug; 20(8):2721-6. PubMed ID: 23463093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
    Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
    Chen G; Wang Z; Liu XY; Liu FY
    Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
    Sun ZG; Wang Z
    Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.
    Sun ZG; Wang Z; Liu XY; Liu FY
    World J Surg; 2011 Jan; 35(1):70-7. PubMed ID: 21046381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
    Chen G; Wang Z; Liu XY; Liu FY
    World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
    Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
    Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Song Y; Wang Z; Liu X; Jiang W; Shi M
    Ann Surg Oncol; 2012 Oct; 19(11):3606-12. PubMed ID: 22644515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients.
    Akhtar J; Wang Z; Jiang WP; Bi MM; Zhang ZP
    J Gastroenterol Hepatol; 2014 May; 29(5):944-50. PubMed ID: 24372619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
    Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
    Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
    Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
    J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
    Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
    World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.
    Liu J; Hu Y; Xie X; Fu J
    Ann Thorac Surg; 2012 Feb; 93(2):423-7. PubMed ID: 22178587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
    Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomy.
    Yu Y; Wang Z; Yang Z; Liu XY
    Med Oncol; 2015 Feb; 32(2):348. PubMed ID: 25572804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.